SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-016669
Filing Date
2019-11-08
Accepted
2019-11-08 08:16:17
Documents
48
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 757118
2 ex31-1.htm EX-31.1 18085
3 ex32-1.htm EX-32.1 6873
  Complete submission text file 0001493152-19-016669.txt   3146431

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lixt-20190930.xml EX-101.INS 462838
5 XBRL SCHEMA FILE lixt-20190930.xsd EX-101.SCH 48557
6 XBRL CALCULATION FILE lixt-20190930_cal.xml EX-101.CAL 28962
7 XBRL DEFINITION FILE lixt-20190930_def.xml EX-101.DEF 146096
8 XBRL LABEL FILE lixt-20190930_lab.xml EX-101.LAB 291653
9 XBRL PRESENTATION FILE lixt-20190930_pre.xml EX-101.PRE 201392
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 000-51476 | Film No.: 191202177
SIC: 2834 Pharmaceutical Preparations